Cargando…
Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal
The use of a combination inhaler containing budesonide and formoterol as both maintenance and quick relief therapy (SMART) has been recommended as an improved method of using inhaled corticosteroid/long-acting β agonist (ICS/LABA) therapy. Published double-blind trials show that budesonide/formotero...
Autores principales: | Chapman, Kenneth R, Barnes, Neil C, Greening, Andrew P, Jones, Paul W, Pedersen, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975956/ https://www.ncbi.nlm.nih.gov/pubmed/20581409 http://dx.doi.org/10.1136/thx.2009.128504 |
Ejemplares similares
-
The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2016) -
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations
por: Kuna, P, et al.
Publicado: (2007) -
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
por: Bateman, Eric D, et al.
Publicado: (2011) -
A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management
por: Louis, R, et al.
Publicado: (2009) -
Biomarkers and severe asthma: a critical appraisal
por: Chiappori, Alessandra, et al.
Publicado: (2015)